180 related articles for article (PubMed ID: 33914296)
1. A Phase I Clinical Trial to Assess Safety and Tolerability of Injectable Collagenase in Women with Symptomatic Uterine Fibroids.
Singh B; Sims H; Trueheart I; Simpson K; Wang KC; Patzkowsky K; Wegman T; Soma JM; Dixon R; Jayes F; Voegltine K; Yenokyan G; Su SC; Leppert P; Segars JH
Reprod Sci; 2021 Sep; 28(9):2699-2709. PubMed ID: 33914296
[TBL] [Abstract][Full Text] [Related]
2. Injectable Clostridium histolyticum collagenase as a potential treatment for uterine fibroids.
Brunengraber LN; Jayes FL; Leppert PC
Reprod Sci; 2014 Dec; 21(12):1452-9. PubMed ID: 25332216
[TBL] [Abstract][Full Text] [Related]
3. Loss of stiffness in collagen-rich uterine fibroids after digestion with purified collagenase Clostridium histolyticum.
Jayes FL; Liu B; Moutos FT; Kuchibhatla M; Guilak F; Leppert PC
Am J Obstet Gynecol; 2016 Nov; 215(5):596.e1-596.e8. PubMed ID: 27177523
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.
Islam MS; Afrin S; Singh B; Jayes FL; Brennan JT; Borahay MA; Leppert PC; Segars JH
Clin Transl Med; 2021 Jul; 11(7):e475. PubMed ID: 34323413
[TBL] [Abstract][Full Text] [Related]
5. Using rheology to quantify the effects of localized collagenase treatments on uterine fibroid digestion.
Corder RD; Gadi SV; Vachieri RB; Jayes FL; Cullen JM; Khan SA; Taylor DK
Acta Biomater; 2021 Oct; 134():443-452. PubMed ID: 34371168
[TBL] [Abstract][Full Text] [Related]
6. Evidence of biomechanical and collagen heterogeneity in uterine fibroids.
Jayes FL; Liu B; Feng L; Aviles-Espinoza N; Leikin S; Leppert PC
PLoS One; 2019; 14(4):e0215646. PubMed ID: 31034494
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies.
Gelbard M; Goldstein I; Hellstrom WJ; McMahon CG; Smith T; Tursi J; Jones N; Kaufman GJ; Carson CC
J Urol; 2013 Jul; 190(1):199-207. PubMed ID: 23376148
[TBL] [Abstract][Full Text] [Related]
9. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
10. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
11. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract][Full Text] [Related]
12. Role of vitamin D in uterine fibroid biology.
Brakta S; Diamond JS; Al-Hendy A; Diamond MP; Halder SK
Fertil Steril; 2015 Sep; 104(3):698-706. PubMed ID: 26079694
[TBL] [Abstract][Full Text] [Related]
13. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of sonographically guided high-intensity focused ultrasound for symptomatic uterine fibroids: preliminary study of a modified protocol.
Leung JH; Yu SC; Cheung EC; Wong AS; Tong MM; Ho SS; Leung VY; Ahuja AT
J Ultrasound Med; 2014 Oct; 33(10):1811-8. PubMed ID: 25253828
[TBL] [Abstract][Full Text] [Related]
15. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of uterine fibroids with ulipristal acetate ☆.
Donnez J; Vázquez F; Tomaszewski J; Nouri K; Bouchard P; Fauser BC; Barlow DH; Palacios S; Donnez O; Bestel E; Osterloh I; Loumaye E;
Fertil Steril; 2014 Jun; 101(6):1565-73.e1-18. PubMed ID: 24630081
[TBL] [Abstract][Full Text] [Related]
17. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.
Yerushalmi GM; Gilboa Y; Jakobson-Setton A; Tadir Y; Goldchmit C; Katz D; Seidman DS
Fertil Steril; 2014 Feb; 101(2):496-500. PubMed ID: 24220703
[TBL] [Abstract][Full Text] [Related]
18. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.
Sangkomkamhang US; Lumbiganon P; Laopaiboon M; Mol BW
Cochrane Database Syst Rev; 2013 Feb; (2):CD008994. PubMed ID: 23450594
[TBL] [Abstract][Full Text] [Related]
19. PROMISe trial: a pilot, randomized, placebo-controlled trial of magnetic resonance guided focused ultrasound for uterine fibroids.
Jacoby VL; Kohi MP; Poder L; Jacoby A; Lager J; Schembri M; Rieke V; Grady D; Vittinghoff E; Coakley FV
Fertil Steril; 2016 Mar; 105(3):773-780. PubMed ID: 26658133
[TBL] [Abstract][Full Text] [Related]
20. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation.
Zhao WP; Chen JY; Chen WZ
Ultrasound Med Biol; 2015 Feb; 41(2):423-31. PubMed ID: 25542494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
